Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate E Broderick

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Cell Reports. Medicine|July 15, 2022
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivoEbony N Gary, Nicholas J Tursi, Bryce Warner, et al.
Human Vaccines & Immunotherapeutics|December 5, 2019
Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challengeHyeree Choi, Sagar B Kudchodkar, Emma L Reuschel, et al.
Journal of Clinical Microbiology|August 29, 2020
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsSusanne N Walker, Neethu Chokkalingam, Emma L Reuschel, et al.
Frontiers in Immunology|December 1, 2025
Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteersJoseph T Agnes, Sarah A Marcus, Sahem S Al-Ghraibeh, et al.
Science Translational Medicine|October 12, 2012
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responsesMark L Bagarazzi, Jian Yan, Matthew P Morrow, et al.
Plos One|April 5, 2013
HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in miceViraj Kulkarni, Margherita Rosati, Antonio Valentin, et al.
Communications Medicine|November 28, 2024
The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa feverViviane M Andrade, Kathleen Cashman, Kyle Rosenke, et al.
The Journal of Infectious Diseases|March 21, 2019
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy VolunteersPablo Tebas, Kimberly A Kraynyak, Ami Patel, et al.
NPJ Vaccines|October 21, 2020
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike proteinAlexander J McAuley, Michael J Kuiper, Peter A Durr, et al.
NPJ Vaccines|December 22, 2017
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infectionsSarah T C Elliott, Nicole L Kallewaard, Ebony Benjamin, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Cell Reports. Medicine|July 15, 2022
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivoEbony N Gary, Nicholas J Tursi, Bryce Warner, et al.
Human Vaccines & Immunotherapeutics|December 5, 2019
Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challengeHyeree Choi, Sagar B Kudchodkar, Emma L Reuschel, et al.
Journal of Clinical Microbiology|August 29, 2020
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsSusanne N Walker, Neethu Chokkalingam, Emma L Reuschel, et al.
Frontiers in Immunology|December 1, 2025
Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteersJoseph T Agnes, Sarah A Marcus, Sahem S Al-Ghraibeh, et al.
Science Translational Medicine|October 12, 2012
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responsesMark L Bagarazzi, Jian Yan, Matthew P Morrow, et al.
Plos One|April 5, 2013
HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in miceViraj Kulkarni, Margherita Rosati, Antonio Valentin, et al.
Communications Medicine|November 28, 2024
The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa feverViviane M Andrade, Kathleen Cashman, Kyle Rosenke, et al.
The Journal of Infectious Diseases|March 21, 2019
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy VolunteersPablo Tebas, Kimberly A Kraynyak, Ami Patel, et al.
NPJ Vaccines|October 21, 2020
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike proteinAlexander J McAuley, Michael J Kuiper, Peter A Durr, et al.
NPJ Vaccines|December 22, 2017
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infectionsSarah T C Elliott, Nicole L Kallewaard, Ebony Benjamin, et al.
Pageof 11